GPAT

Business Context and Reporting Period

Company: GP-Act III Acquisition Corp. (GPAT)

Reporting Period: Quarter ended September 30, 2024 (Q3 2024)

Status: The Company is a Cayman Islands exempted company and a "blank check" SPAC formed to effect a business combination. It has not commenced operations. On May 13, 2024, the Company consummated its Initial Public Offering (IPO) of 28,750,000 units (including full over-allotment exercise) at $10.00 per unit, generating gross proceeds of $287,500,000. Simultaneously, it sold 7,000,000 Private Placement Warrants for $7,000,000.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue and Income: The Company reported a net income of $3.66 million for Q3 2024, a significant shift from the net loss of $616 in Q3 2023. This change is driven entirely by interest income earned on the Trust Account following the May 2024 IPO. Prior to the IPO, the Company had no operations and generated no revenue.
• Assets: Total assets increased from $530,238 as of December 31, 2023, to $294,096,533 as of September 30, 2024. This is primarily due to the placement of $287.5 million in the Trust Account.
• Liabilities: Total liabilities increased from $628,182 to $14,596,275. The increase is largely attributable to the recording of a $13,687,500 deferred underwriting fee and $350,000 in deferred legal fees, which are contingent upon the completion of a business combination.
• Cash Flow: Net cash used in operating activities was $554,783 for the nine months ended September 30, 2024, compared to $433 in the same period in 2023. Financing activities provided $288.6 million in net cash during the nine-month period due to the IPO and private placement proceeds.

Outlook, Risks, and Contingencies

• Business Combination Deadline: The Company has 24 months from the closing of the IPO (May 13, 2024) to complete a business combination. If unsuccessful, the Company will liquidate and redeem public shares.
• Going Concern: Management has raised substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time (one year) if a business combination is not consummated. The financial statements do not include adjustments related to the recovery of assets or classification of liabilities that might be necessary in a liquidation scenario.
• Liquidity: The Company holds $513,507 in cash outside the Trust Account to fund operations. It may require additional financing (Working Capital Loans) from the Sponsor or affiliates to meet operating expenses or transaction costs. Up to $1.5 million of such loans may be convertible into warrants.
• Geopolitical Risks: The filing highlights risks associated with the Russia-Ukraine conflict and the Israel-Hamas conflict, which could cause market volatility, supply chain interruptions, and instability in capital markets, potentially affecting the search for a target business.
• Warrant Redemption: Public warrants may be redeemed if the Class A share price exceeds $18.00 per share for 20 trading days within a 30-day period, subject to specific conditions.

Investor Verification Checklist

• Trust Account Yield: Verify the current interest rate environment and its impact on the Trust Account balance, which currently stands at approximately $10.20 per share ($293,247,982 / 28,750,000 shares).
• Deferred Fees: Confirm the terms of the $13,687,500 deferred underwriting fee and $350,000 deferred legal fee, noting they are only payable upon a successful business combination.
• Related Party Loans: Review the status of the $400,000 outstanding promissory notes from related parties and the potential for additional Working Capital Loans.
• Share Redemption Rights: Understand the redemption rights of public shareholders, including the 15% limit on redemption without consent if a shareholder vote is held.
• Extension Options: Check the Company's charter for any provisions allowing extensions of the 24-month combination period, which may require shareholder approval or additional funding.